Eight officers depart major corps; small-caps face delisting pressure

Eight officers depart major corps; small-caps face delisting pressure

Eight companies disclosed officer departures in a single filing batch on May 8, including blue-chip names Edwards Lifesciences (EW), FedEx (FDX), and Baxter International (BAX), signaling broad executive churn across healthcare, logistics, and other sectors. ADT Inc. (ADT), Pool Corp. (POOL), Nu Skin Enterprises (NUS), and Crescent Capital BDC (CCAP) also reported departures. Separately, small-cap Cryo Cell International (CCELL) filed a delisting notice. This week's aggregate risk leaderboard flags La Rosa Holdings (LRHC) and Fermi Inc. (FRMI) as elevated-concern names, with Sangamo Therapeutics (SGMOQ) and Quetta Acquisition (QETA) showing concentrated delisting risk. Monitor follow-up proxy statements and 14A filings to determine whether departures reflect routine succession or material operational strain.